Veracyte (VCYT) Current Deferred Tax Assets (2014 - 2015)

Veracyte (VCYT) posted quarterly Current Deferred Tax Assets of $222000.0 for Q3 2015, down 31.69% year-over-year from $325000.0 in Q3 2014, and down 12.6% on a QoQ basis from $254000.0 in Q2 2015.

Veracyte (VCYT) Current Deferred Tax Assets (2014 - 2015) Analysis & Trends

Veracyte has reported Current Deferred Tax Assets for 2 years, with the latest figure at $222000.0 in Q3 2015.

  • Current Deferred Tax Assets for Q3 2015 came in at $222000.0, down 31.69% year-over-year; the trailing twelve-month figure through Sep 2015 was $222000.0 (down 31.69% YoY), and the FY2014 annual result was $300000.0, changed N/A from the prior year.
  • Current Deferred Tax Assets declined to $222000.0 in Q3 2015, from $254000.0 in the prior quarter.
  • Over five years, Current Deferred Tax Assets peaked at $325000.0 in Q3 2014 and troughed at $222000.0 in Q3 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.44 Bn 209.37 Bn 8.34 Bn
2 Danaher 139.95 Bn 135.60 Bn 3.61 Bn
3 Idexx Laboratories 46.16 Bn 45.96 Bn 779.09 Mn
4 Agilent Technologies 39.67 Bn 37.87 Bn 990.00 Mn
5 Iqvia Holdings 39.29 Bn 37.21 Bn 1.44 Bn
6 Natera 38.61 Bn 37.51 Bn 696.04 Mn
7 Illumina 29.99 Bn 28.82 Bn 770.00 Mn
8 Mettler Toledo International 28.57 Bn 28.51 Bn 650.22 Mn
9 Quest Diagnostics 26.17 Bn 25.55 Bn 1.03 Bn
10 Veracyte 3.68 Bn 3.38 Bn 108.55 Mn

Historic Data

Download Data
DateValue
Sep 30, 2015 222,000.00
Sep 30, 2015 222,000.00
Jun 30, 2015 254,000.00
Jun 30, 2015 254,000.00
Mar 31, 2015 300,000.00
Mar 31, 2015 300,000.00
Dec 31, 2014 300,000.00
Dec 31, 2014 300,000.00
Sep 30, 2014 325,000.00
Sep 30, 2014 325,000.00